Meet Our Scientists

Narrow By

Refine Alphabetically

Yona Lunsky

Dr. Yona Lunsky

Scientific Director, Azrieli Adult Neurodevelopmental Centre

yona.lunsky@camh.ca About Dr. Yona Lunsky
Dr. Marta Maslej profile photo

Dr. Marta Maslej

Staff Scientist, Krembil Centre for Neuroinformatics

marta.maslej@camh.ca About Dr. Marta Maslej
Dr. Joyce Mason, Health Economist, Scientist, Institute for Mental Health Policy Research

Dr. Joyce Mason

Scientist, Institute for Mental Health Policy Research

Joyce.Mason@camh.ca About Dr. Joyce Mason
Dr. Kwame McKenzie

Dr. Kwame McKenzie

Senior Scientist and Director of Health Equity, Institute for Mental Health Policy Research

kwame.mckenzie@camh.ca About Dr. Kwame McKenzie
Shelley McMain

Dr. Shelley McMain

Senior Scientist, General Adult Psychiatry and Health Systems Division

shelley.mcmain@camh.ca About Dr. Shelley McMain
Dr. Osnat Melamed

Dr. Osnat C. Melamed

Associate Scientist, Addictions Division

Osnat.Melamed@camh.ca About Dr. Osnat C. Melamed
Jeff Meyer

Dr. Jeffrey Meyer

Senior Scientist, Brain Health Imaging Centre

jeff.meyer@camh.ca About Dr. Jeffrey Meyer
Dr. Nadia Minian

Dr. Nadia Minian

Scientist, Institute for Mental Health Policy Research

nadia.minian2@camh.ca About Dr. Nadia Minian
Dr. Daniel Mueller

Dr. Daniel Mueller

Associate Scientist, Molecular Science, Pharmacogenetics Research Clinic

daniel.mueller@camh.ca About Dr. Daniel Mueller
Dr. Benoit Mulsant

Dr. Benoit H. Mulsant

Senior Scientist, Adult Neurodevelopment and Geriatric Psychiatry Division

Benoit.Mulsant@camh.ca About Dr. Benoit H. Mulsant
Photo of a cannabis leaf and a maple leaf

New Study Highlights Ethical Challenges in Conducting Cannabis Research in Canada

CAMH-led research reveals systemic barriers and ethical considerations in industry-funded cannabis research in Canada

Read More
Photo of a syring, vial, mask and stethoscope

Extended-Release Buprenorphine for Opioid Use Disorder Treatment in Correctional Settings

To understand treatment best practices, researchers at CAMH conducted the first comprehensive review of available studies that evaluate the use of extended-release buprenorphine as a treatment for OUD within correctional facilities.

Read More
Doctor speaking to a patient while looking at a tablet

New study shows combination therapy slows cognitive decline in at-risk populations

CAMH-led TDRA study represents multi-site collaboration to improve mental health of older adults

Read More
See all news
DONATE